CLYM
Climb Bio Inc
NASDAQ: CLYM · HEALTHCARE · BIOTECHNOLOGY
$8.88
+1.14% today
Updated 2026-04-30
Market cap
$436.60M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.88
Dividend yield
—
52W range
$1 – $10
Volume
0.6M
Climb Bio Inc (CLYM) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-32.20%
ROA
-22.00%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | — | $-6.55M | — | — | — |
| 2020 | $0.00 | $-20.67M | — | — | — |
| 2021 | $0.00 | $-47.48M | — | — | — |
| 2022 | $0.00 | $-45.24M | — | — | — |
| 2023 | $0.00 | $-35.12M | — | — | — |
| 2024 | $0.00 | $-73.90M | — | — | — |
| 2025 | $0.00 | $-59.85M | — | — | — |